Beckman's automated PSA (prostate specific antigen) tests receive FDA green light
This article was originally published in Clinica
Executive Summary
Beckman Coulter has received a premarket approval from the US FDA for its automated Hybritech total PSA and Hybritech free PSA blood tests, designed for the diagnosis of prostate cancer.